⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16516346 | 0.77 | KDM4E (0.32) | — | |
| SCHEMBL2959935 | 0.76 | — | — | |
| SCHEMBL11344440 | 0.76 | — | — | |
| SCHEMBL6662338 | 0.76 | — | — | |
| SCHEMBL28786018 | 0.75 | LMNA (0.32) | — | |
| SCHEMBL27676666 | 0.74 | — | — | |
| Phosphine SCHEMBL28108307 | 0.74 | CA1 (0.32) | — | |
| Water SCHEMBL9696832 | 0.74 | KDM4E (0.35) | — | |
| SCHEMBL4259788 | 0.72 | NOS1 (0.38) | — | |
| Acetonitrile SCHEMBL28126168 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119615168-A | Silver film etching solution and application thereof | 合肥中聚和成电子材料有限公司 | 2025-03-14 | — | — | CN | claimed |
| EP-2338923-B1 | Polyurethane with a biocidal polyuric material as comonomer | OBERWALDER SEBASTIAN (DE) | 2017-10-18 | — | — | EP | claimed |
| CN-102617308-B | Olefin two-phase hydroformylation method | UNIV QINGDAO SCIENCE & TECHNOLOGY | 2013-11-27 | — | — | CN | claimed |
| CN-102617308-A | Olefin two-phase hydroformylation method | UNIV QINGDAO SCIENCE & TECHNOLOGY | 2012-08-01 | — | — | CN | claimed |
| CN-102365024-A | Compounds, compositions and methods for preventing metastasis of cancer cells | AKEBIA THERAPEUTICS INC | 2012-02-29 | — | — | CN | claimed |
| CN-1729172-A | Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity | SIGMA TAU IND FARMACEUTI (IT) | 2006-02-01 | — | — | CN | claimed |
| CN-119615168-A | Silver film etching solution and application thereof | 合肥中聚和成电子材料有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-117384106-A | Preparation method of high-purity proton type organic salt for phase-change energy storage | 四川大学 | 2024-01-12 | — | — | CN | disclosed |
| CN-109894147-B | Supported cobalt-based catalyst and preparation method and use method thereof | 中科合成油技术股份有限公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-109894147-A | A kind of load type cobalt-base catalyst and preparation method thereof and application method | 中科合成油技术有限公司 | 2019-06-18 | — | — | CN | disclosed |
| US-9868682-B2 | Production of partially refined waste glycerol | REG Life Sciences, LLC (US) | 2018-01-16 | — | — | US | disclosed |
| CN-103459393-B | Preparation of bicyclic guanidine salts in aqueous media | PPG工业俄亥俄公司 | 2017-06-20 | — | — | CN | disclosed |
| CN-104710289-B | Method for olefin hydroformylation reaction through adopting solid heterogeneous catalyst | 中国科学院大连化学物理研究所 | 2017-04-19 | — | — | CN | disclosed |
| US-6143791-A | NERVOUS SYSTEM DISORDERS | CAMBRIDGE NEUROSCIENCE, INC. (US) | 2000-11-07 | — | — | US | disclosed |
| CN-1196721-A | Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof | YAMANOUCHI PHARMA CO LTD (JP) | 1998-10-21 | — | — | CN | disclosed |
| US-5688946-A | DIPEPTIDES FOR HYPOTENSIVE AGENTS AND CARDIOVASCULAR DISORDERS | HOFFMANN LA ROCHE INC. (US) | 1997-11-18 | — | — | US | disclosed |
| CN-1158606-A | Benzoylguanidine derivatives as medicaments | FUJISAWA PHARMACEUTICAL CO (JP) | 1997-09-03 | — | — | CN | disclosed |
| EP-0773927-A2 | BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-05-21 | — | — | EP | disclosed |
| CN-1126434-A | Therapeutic substituted guanidines | CAMBRIDGE NEUROSCIENCE INC (US) | 1996-07-10 | — | — | CN | disclosed |
| WO-1996004241-A2 | BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-02-15 | — | — | WO | disclosed |